Corebridge Financial Inc. trimmed its position in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 6.0% during the 4th quarter, HoldingsChannel.com reports. The firm owned 31,613 shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback